Non-erythropoietic erythropoietin derivatives protect from light-induced and genetic photoreceptor degeneration

Human Molecular Genetics

Volumn 20, Issue 11, 2011, Pages 2251-2262

  Colella, Pasqualina ^a,b   Iodice, Carolina ^a   Di Vicino, Umberto ^a   Annunziata, Ida ^a   Surace, Enrico M ^a   Auricchio, Alberto ^a,c  

^a TELETHON INSTITUTE OF GENETICS AND MEDICINE TIGEM   (Italy)

^b OPEN UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BETA COMMON RECEPTOR; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; HORMONE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DRUG ACTIVITY; DRUG EFFICACY; ERYTHROPOIESIS; GENE TARGETING; GENE TRANSFER; HEMATOCRIT; MOUSE; NONHUMAN; PHOTORECEPTOR; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; RETINA DEGENERATION; SURVIVAL;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; DEPENDOVIRUS; ERYTHROPOIESIS; ERYTHROPOIETIN; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEMATOCRIT; INTERMEDIATE FILAMENT PROTEINS; LIGHT; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, KNOCKOUT; MODELS, ANIMAL; MUTATION; NERVE TISSUE PROTEINS; PHOTORECEPTOR CELLS, VERTEBRATE; RATS; RATS, INBRED LEW; RETINAL DEGENERATION;

ANIMALIA;

EID: 79956028072     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr115     Document Type: Article

References (96)

1. Hartong, D.T., Berson, E.L. and Dryja, T.P. (2006) Retinitis pigmentosa. Lancet, 368, 1795-1809.
2. den Hollander, A.I., Roepman, R., Koenekoop, R.K. and Cremers, F.P. (2008) Leber congenital amaurosis: genes, proteins and disease mechanisms. Prog. Retin. Eye Res., 27, 391-419.
3. Hamel, C.P. (2007) Cone rod dystrophies. Orphanet J. Rare Dis., 2, 7.
4. Marigo, V. (2007) Programmed cell death in retinal degeneration: targeting apoptosis in photoreceptors as potential therapy for retinal degeneration. Cell Cycle, 6, 652-655.
5. Wright, A.F., Chakarova, C.F., Abd El-Aziz, M.M. and Bhattacharya, S.S. (2010) Photoreceptor degeneration: genetic and mechanistic dissection of a complex trait. Nat. Rev. Genet., 11, 273-284.
6. LaVail, M.M., Yasumura, D., Matthes, M.T., Lau-Villacorta, C., Unoki, K., Sung, C.H. and Steinberg, R.H. (1998) Protection of mouse photoreceptors by survival factors in retinal degenerations. Invest. Ophthalmol. Vis. Sci., 39, 592-602.
7. Wenzel, A., Grimm, C., Samardzija, M. and Reme, C.E. (2005) Molecular mechanisms of light-induced photoreceptor apoptosis and neuroprotection for retinal degeneration. Prog. Retin. Eye Res., 24, 275-306.
8. Allocca, M., Tessitore, A., Cotugno, G. and Auricchio, A. (2006) AAV-mediated gene transfer for retinal diseases. Expert Opin. Biol. Ther., 6, 1279-1294.
9. Buch, P.K., MacLaren, R.E. and Ali, R.R. (2007) Neuroprotective gene therapy for the treatment of inherited retinal degeneration. Curr. Gene Ther., 7, 434-445.
10. Colella, P., Cotugno, G. and Auricchio, A. (2009) Ocular gene therapy: current progress and future prospects. Trends Mol. Med., 15, 23-31.
11. Maiese, K., Chong, Z.Z., Li, F. and Shang, Y.C. (2008) Erythropoietin: elucidating new cellular targets that broaden therapeutic strategies. Prog. Neurobiol., 85, 194-213.
12. Brines, M. and Cerami, A. (2005) Emerging biological roles for erythropoietin in the nervous system. Nat. Rev. Neurosci., 6, 484-494.
13. Hasselblatt, M., Ehrenreich, H. and Siren, A.L. (2006) The brain erythropoietin system and its potential for therapeutic exploitation in brain disease. J. Neurosurg. Anesthesiol., 18, 132-138.
14. Youssoufian, H., Longmore, G., Neumann, D., Yoshimura, A. and Lodish, H.F. (1993) Structure, function, and activation of the erythropoietin receptor. Blood, 81, 2223-2236.
15. Um, M., Gross, A.W. and Lodish, H.F. (2007) A 'classical' homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells. Cell. Signal., 19, 634-645.
16. Masuda, S., Nagao, M., Takahata, K., Konishi, Y., Gallyas, F. Jr., Tabira, T. and Sasaki, R. (1993) Functional erythropoietin receptor of the cells with neural characteristics. Comparison with receptor properties of erythroid cells. J. Biol. Chem., 268, 11208-11216.
17. Sakanaka, M., Wen, T.C., Matsuda, S., Masuda, S., Morishita, E., Nagao, M. and Sasaki, R. (1998) In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc. Natl Acad. Sci. USA, 95, 4635-4640.
18. Siren, A.L., Knerlich, F., Poser, W., Gleiter, C.H., Bruck, W. and Ehrenreich, H. (2001) Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain. Acta Neuropathol., 101, 271-276.
19. Chen, Z.Y., Asavaritikrai, P., Prchal, J.T. and Noguchi, C.T. (2007) Endogenous erythropoietin signaling is required for normal neural progenitor cell proliferation. J. Biol. Chem., 282, 25875-25883.
20. Sanchez, P.E., Fares, R.P., Risso, J.J., Bonnet, C., Bouvard, S., Le-Cavorsin, M., Georges, B., Moulin, C., Belmeguenai, A., Bodennec, J. et al. (2009) Optimal neuroprotection by erythropoietin requires elevated expression of its receptor in neurons. Proc. Natl Acad. Sci. USA, 106, 9848-9853.
21. Hanazono, Y., Sasaki, K., Nitta, H., Yazaki, Y. and Hirai, H. (1995) Erythropoietin induces tyrosine phosphorylation of the beta chain of the GM-CSF receptor. Biochem. Biophys. Res. Commun., 208, 1060-1066.
22. Jubinsky, P.T., Krijanovski, O.I., Nathan, D.G., Tavernier, J. and Sieff, C.A. (1997) The beta chain of the interleukin-3 receptor functionally associates with the erythropoietin receptor. Blood, 90, 1867-1873.
23. Blake, T.J., Jenkins, B.J., D'Andrea, R.J. and Gonda, T.J. (2002) Functional cross-talk between cytokine receptors revealed by activating mutations in the extracellular domain of the beta-subunit of the GM-CSF receptor. J. Leukoc. Biol., 72, 1246-1255.
24. Su, K.H., Shyue, S.K., Kou, Y.R., Ching, L.C., Chiang, A.N., Yu, Y.B., Chen, C.Y., Pan, C.C. and Lee, T.S. (2011) Beta common receptor integrates the erythropoietin signaling in activation of endothelial nitric oxide synthase. J. Cell. Physiol.
25. Brines, M., Grasso, G., Fiordaliso, F., Sfacteria, A., Ghezzi, P., Fratelli, M., Latini, R., Xie, Q.W., Smart, J., Su-Rick, C.J. et al. (2004) Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor. Proc. Natl Acad. Sci. USA, 101, 14907-14912.
26. Nadam, J., Navarro, F., Sanchez, P., Moulin, C., Georges, B., Laglaine, A., Pequignot, J.M., Morales, A., Ryvlin, P. and Bezin, L. (2007) Neuroprotective effects of erythropoietin in the rat hippocampus after pilocarpine-induced status epilepticus. Neurobiol. Dis., 25, 412-426.
27. Sanchez, P.E., Navarro, F.P., Fares, R.P., Nadam, J., Georges,B.,Moulin,C., Le Cavorsin, M., Bonnet, C., Ryvlin, P., Belmeguenai, A. et al. (2009) Erythropoietin receptor expression is concordant with erythropoietin but not with common beta chain expression in the rat brain throughout the life span. J. Comp. Neurol., 514, 403-414.
28. Grimm, C., Wenzel, A., Groszer, M., Mayser, H., Seeliger, M., Samardzija, M., Bauer, C., Gassmann, M. and Reme, C.E. (2002) HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat. Med., 8, 718-724.
29. Junk, A.K., Mammis, A., Savitz, S.I., Singh, M., Roth, S., Malhotra, S., Rosenbaum, P.S., Cerami, A., Brines, M. and Rosenbaum, D.M. (2002) Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proc. Natl Acad. Sci. USA, 99, 10659-10664.
30. Chen, J., Connor, K.M., Aderman, C.M. and Smith, L.E. (2008) Erythropoietin deficiency decreases vascular stability in mice. J. Clin. Invest., 118, 526-533.
31. Munro, K., Rees, S., O'Dowd, R. and Tolcos, M. (2009) Developmental profile of erythropoietin and its receptor in guinea-pig retina. Cell Tissue Res., 336, 21-29.
32. Brines, M.L., Ghezzi, P., Keenan, S., Agnello, D., de Lanerolle, N.C., Cerami, C., Itri, L.M. and Cerami, A. (2000) Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc. Natl Acad. Sci. USA, 97, 10526-10531.
33. Rex, T.S., Allocca, M., Domenici, L., Surace, E.M., Maguire, A.M., Lyubarsky, A., Cellerino, A., Bennett, J. and Auricchio, A. (2004) Systemic but not intraocular Epo gene transfer protects the retina from light-and genetic-induced degeneration. Mol. Ther., 10, 855-861.
34. Grimm, C., Hermann, D.M., Bogdanova, A., Hotop, S., Kilic, U., Wenzel, A., Kilic, E. and Gassmann, M. (2005) Neuroprotection by hypoxic preconditioning: HIF-1 and erythropoietin protect fromretinal degeneration. Semin. Cell Dev. Biol., 16, 531-538.
35. Grimm, C., Wenzel, A., Acar, N., Keller, S., Seeliger, M. and Gassmann, M. (2006) Hypoxic preconditioning and erythropoietin protect retinal neurons from degeneration. Adv. Exp. Med. Biol., 588, 119-131.
36. Zhong, L., Bradley, J., Schubert, W., Ahmed, E., Adamis, A.P., Shima, D.T., Robinson, G.S. and Ng, Y.S. (2007) Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice. Invest. Ophthalmol. Vis. Sci., 48, 1212-1218.
37. King, C.E., Rodger, J., Bartlett, C., Esmaili, T., Dunlop, S.A. and Beazley, L.D. (2007) Erythropoietin is both neuroprotective and neuroregenerative following optic nerve transection. Exp. Neurol., 205, 48-55.
38. Tsai, J.C., Wu, L., Worgul, B., Forbes, M. and Cao, J. (2005) Intravitreal administration of erythropoietin and preservation of retinal ganglion cells in an experimental rat model of glaucoma. Curr. Eye Res., 30, 1025-1031.
39. Rex, T.S., Wong, Y., Kodali, K. and Merry, S. (2009) Neuroprotection of photoreceptors by direct delivery of erythropoietin to the retina of the retinal degeneration slow mouse. Exp. Eye Res., 89, 735-740.
40. Zhang, J., Wu, Y., Jin, Y., Ji, F., Sinclair, S.H., Luo, Y., Xu, G., Lu, L., Dai, W., Yanoff, M. et al. (2008) Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes. Invest. Ophthalmol. Vis. Sci., 49, 732-742.
41. Auricchio, A., Rivera, V.M., Clackson, T., O'Connor, E.E., Maguire, A.M., Tolentino, M.J., Bennett, J. and Wilson, J.M. (2002) Pharmacological regulation of protein expression from adeno-associated viral vectors in the eye. Mol. Ther., 6, 238-242.
42. Lebherz, C., Auricchio, A., Maguire, A.M., Rivera, V.M., Tang, W., Grant, R.L., Clackson, T., Bennett, J. and Wilson, J.M. (2005) Long-term inducible gene expression in the eye via adeno-associated virus gene transfer in nonhuman primates. Hum. Gene Ther., 16, 178-186.
43. Rosenzweig,M.Q., Bender, C.M., Lucke, J.P.,Yasko, J.M. andBrufsky, A.M. (2004) The decision to prematurely terminate a trial of R-HuEPO due to thrombotic events. J. Pain Symptom Manage., 27, 185-190.
44. Stohlawetz, P.J., Dzirlo, L., Hergovich, N., Lackner, E., Mensik, C., Eichler, H.G., Kabrna, E., Geissler, K. and Jilma, B. (2000) Effects of erythropoietin on platelet reactivity and thrombopoiesis in humans. Blood, 95, 2983-2989.
45. Kirkeby, A., Torup, L., Bochsen, L.,Kjalke,M., Abel, K., Theilgaard-Monch, K., Johansson, P.I., Bjorn, S.E., Gerwien, J. and Leist, M. (2008) High-dose erythropoietin alters platelet reactivity and bleeding time in rodents in contrast to the neuroprotective variant carbamyl-erythropoietin (CEPO). Thromb. Haemost., 99, 720-728.
46. Campana, W.M., Misasi, R. and O'Brien, J.S. (1998) Identification of a neurotrophic sequence in erythropoietin. Int. J. Mol. Med., 1, 235-241.
47. Leist, M., Ghezzi, P., Grasso, G., Bianchi, R., Villa, P., Fratelli, M., Savino, C., Bianchi, M., Nielsen, J., Gerwien, J. et al. (2004) Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science, 305, 239-242.
48. Brines, M., Patel, N.S., Villa, P., Brines, C., Mennini, T., De Paola, M., Erbayraktar, Z., Erbayraktar, S., Sepodes, B., Thiemermann, C. et al. (2008) Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin. Proc. Natl Acad. Sci. USA, 105, 10925-10930.
49. Brines, M., Cerami, A. and Coleman, T. (2009) Tissue Protective Peptides and Uses Thereof. US Patent Application 2009/0221482. Warren Pharmaceuticals, Inc. Available at http://www.wipo.int/pctdb/en/ wo.jsp?KEY=07%2F019545&IA=US2006031061&DISPLAY=DESC; and http://www.freepatentsonline.com/y2009/0221482.html.
50. Elliott, S., Lorenzini, T., Chang, D., Barzilay, J. and Delorme, E. (1997) Mapping of the active site of recombinant human erythropoietin. Blood, 89, 493-502.
51. Dumont, F. and Bischoff, P. (2010) Non-erythropoietic tissue-protective peptides derived from erythropoietin: WO2009094172. Expert Opin. Ther. Pat., 20, 715-723.
52. Cerami, A. and Brines, M. (2009) Tissue Protective Peptides and Peptides Analogs for Preventing and Treating Diseases and Disorders Associated with Tissue Damage. US Patent Application WO/2009/094172. Araim Pharmaceuticals, Inc. Available at http://www.wipo.int/pctdb/en/ wo.jsp?WO=2009094172.
53. Syed, R.S., Reid, S.W., Li, C., Cheetham, J.C., Aoki, K.H., Liu, B., Zhan, H., Osslund, T.D., Chirino, A.J., Zhang, J. et al. (1998) Efficiency of signalling through cytokine receptors depends critically on receptor orientation. Nature, 395, 511-516.
54. Villa, P., van Beek, J., Larsen, A.K., Gerwien, J., Christensen, S., Cerami, A., Brines, M., Leist, M., Ghezzi, P. and Torup, L. (2007) Reduced functional deficits, neuroinflammation, and secondary tissue damage after treatment of stroke by nonerythropoietic erythropoietin derivatives. J. Cereb. Blood Flow Metab., 27, 552-563.
55. LaVail, M.M., Unoki, K., Yasumura, D., Matthes, M.T., Yancopoulos, G.D. and Steinberg, R.H. (1992) Multiple growth factors, cytokines, and neurotrophins rescue photoreceptors from the damaging effects of constant light. Proc. Natl Acad. Sci. USA, 89, 11249-11253.
56. Chang, B., Hawes, N.L., Hurd, R.E., Davisson, M.T., Nusinowitz, S. and Heckenlively, J.R. (2002) Retinal degeneration mutants in the mouse. Vision Res., 42, 517-525.
57. Dyer, M.A., Donovan, S.L., Zhang, J., Gray, J., Ortiz, A., Tenney, R., Kong, J., Allikmets, R. and Sohocki, M.M. (2004) Retinal degeneration in Aipl1-deficient mice: a new genetic model of Leber congenital amaurosis. Brain Res. Mol. Brain Res., 132, 208-220.
58. Wahlin, K.J., Campochiaro, P.A., Zack, D.J. and Adler, R. (2000) Neurotrophic factors cause activation of intracellular signaling pathways in Muller cells and other cells of the inner retina, but not photoreceptors. Invest. Ophthalmol. Vis. Sci., 41, 927-936.
59. Hauck, S.M., Kinkl, N., Deeg, C.A., Swiatek-de Lange, M., Schoffmann, S. and Ueffing, M. (2006) GDNF family ligands trigger indirect neuroprotective signaling in retinal glial cells. Mol. Cell. Biol., 26, 2746-2757.
60. Auricchio, A., Kobinger, G., Anand, V., Hildinger, M., O'Connor, E., Maguire, A.M., Wilson, J.M. and Bennett, J. (2001) Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model. Hum. Mol. Genet., 10, 3075-3081.
61. Yang, G.S., Schmidt, M., Yan, Z., Lindbloom, J.D., Harding, T.C., Donahue, B.A., Engelhardt, J.F., Kotin, R. and Davidson, B.L. (2002) Virus-mediated transduction of murine retina with adeno-associated virus: effects of viral capsid and genome size. J. Virol., 76, 7651-7660.
62. Rabinowitz, J.E., Rolling, F., Li, C., Conrath, H., Xiao, W., Xiao, X. and Samulski, R.J. (2002) Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. J. Virol., 76, 791-801.
63. Weymouth, A.E. and Vingrys, A.J. (2008) Rodent electroretinography: methods for extraction and interpretation of rod and cone responses. Prog. Retin. Eye Res., 27, 1-44.
64. Brines, M. and Cerami, A. (2008) Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response. J. Intern. Med., 264, 405-432.
65. Sanyal, S. and Jansen, H.G. (1981) Absence of receptor outer segments in the retina of rds mutant mice. Neurosci. Lett., 21, 23-26.
66. Reuter, J.H. and Sanyal, S. (1984) Development and degeneration of retina in rds mutant mice: the electroretinogram. Neurosci. Lett., 48, 231- 237.
67. Chang, G.Q., Hao, Y. and Wong, F. (1993) Apoptosis: final common pathway of photoreceptor death in rd, rds, and rhodopsin mutant mice. Neuron, 11, 595-605.
68. Kirschman, L.T., Kolandaivelu, S., Frederick, J.M., Dang, L., Goldberg, A.F., Baehr, W. and Ramamurthy, V. (2010) The Leber congenital amaurosis protein, AIPL1, is needed for the viability and functioning of cone photoreceptor cells. Hum. Mol. Genet., 19, 1076-1087.
69. Ramamurthy, V., Niemi, G.A., Reh, T.A. and Hurley, J.B. (2004) Leber congenital amaurosis linked to AIPL1: a mouse model reveals destabilization of cGMP phosphodiesterase. Proc. Natl Acad. Sci. USA, 101, 13897-13902.
70. Eschbach, J.W. (1995) The future of r-HuEPO. Nephrol. Dial. Transplant., 10(Suppl. 2), 96-109.
71. Testa, U. (2010) Erythropoietic stimulating agents. Expert Opin. Emerg. Drugs, 15, 119-138.
72. Chung, H., Lee, H., Lamoke, F., Hrushesky, W.J., Wood, P.A. and Jahng, W.J. (2009) Neuroprotective role of erythropoietin by antiapoptosis in the retina. J. Neurosci. Res., 87, 2365-2374.
73. Wang, L., Zhang, Z.G., Zhang, R.L., Gregg, S.R., Hozeska-Solgot, A., LeTourneau, Y., Wang, Y. and Chopp, M. (2006) Matrix metalloproteinase 2 (MMP2) and MMP9 secreted by erythropoietin-activated endothelial cells promote neural progenitor cell migration. J. Neurosci., 26, 5996-6003.
74. Chong, Z.Z., Shang, Y.C. and Maiese, K. (2007) Vascular injury during elevated glucose can be mitigated by erythropoietin and Wnt signaling. Curr. Neurovasc. Res., 4, 194-204.
75. Stieger, K., Le Meur, G., Lasne, F., Weber, M., Deschamps, J.Y., Nivard, D., Mendes-Madeira, A., Provost, N., Martin, L., Moullier, P. et al. (2006) Long-term doxycycline-regulated transgene expression in the retina of nonhuman primates following subretinal injection of recombinant AAV vectors. Mol. Ther., 13, 967-975.
76. Toledo, J.R., Sanchez, O., Segui, R.M., Garcia, G., Montanez, M., Zamora, P.A., Rodriguez, M.P. and Cremata, J.A. (2006) High expression level of recombinant human erythropoietin in the milk of non-transgenic goats. J. Biotechnol., 123, 225-235.
77. Weishaupt, J.H., Rohde, G., Polking, E., Siren, A.L., Ehrenreich, H. and Bahr, M. (2004) Effect of erythropoietin axotomy-induced apoptosis in rat retinal ganglion cells. Invest. Ophthalmol. Vis. Sci., 45, 1514-1522.
78. Keswani, S.C., Leitz, G.J. and Hoke, A. (2004) Erythropoietin is neuroprotective in models of HIV sensory neuropathy. Neurosci. Lett., 371, 102-105.
79. Toth, C., Martinez, J.A., Liu, W.Q., Diggle, J., Guo, G.F., Ramji, N., Mi, R., Hoke, A. and Zochodne, D.W. (2008) Local erythropoietin signaling enhances regeneration in peripheral axons. Neuroscience, 154, 767-783.
80. Grimm,C.,Wenzel, A., Stanescu, D., Samardzija, M.,Hotop, S., Groszer, M., Naash, M., Gassmann, M. and Reme, C. (2004) Constitutive overexpression of human erythropoietin protects the mouse retina against induced but not inherited retinal degeneration. J. Neurosci., 24, 5651-5658.
81. Wen, D., Boissel, J.P., Tracy, T.E., Gruninger, R.H., Mulcahy, L.S., Czelusniak, J., Goodman, M. and Bunn, H.F. (1993) Erythropoietin structure-function relationships: high degree of sequence homology among mammals. Blood, 82, 1507-1516.
82. Sullivan, T., Kodali, K. and Rex, T.S. (2011) Systemic gene delivery protects the photoreceptors in the retinal degeneration slow mouse. Neurochem. Res., 36, 613-618.
83. Chern, Y.J., Chung, T.W. and Sytkowski, A.J. (1991) Structural role of amino acids 99-110 in recombinant human erythropoietin. Eur. J. Biochem., 202, 225-229.
84. Grodberg, J., Davis, K.L. and Sytkowski, A.J. (1996) Functional and structural role of arginine 103 in human erythropoietin. Arch. Biochem. Biophys., 333, 427-431.
85. Vincent-Lacaze, N., Snyder, R.O., Gluzman, R., Bohl, D., Lagarde, C. and Danos, O. (1999) Structure of adeno-associated virus vector DNA following transduction of the skeletal muscle. J. Virol., 73, 1949-1955.
86. Tan, M.H., Smith, A.J., Pawlyk, B., Xu, X., Liu, X., Bainbridge, J.B., Basche, M., McIntosh, J., Tran, H.V., Nathwani, A. et al. (2009) Gene therapy for retinitis pigmentosa and Leber congenital amaurosis caused by defects in AIPL1: effective rescue of mouse models of partial and complete Aipl1 deficiency using AAV2/2 and AAV2/8 vectors. Hum. Mol. Genet., 18, 2099-2114.
87. Sun, X., Pawlyk, B., Xu, X., Liu, X., Bulgakov, O.V., Adamian, M., Sandberg, M.A., Khani, S.C., Tan, M.H., Smith, A.J. et al. (2010) Gene therapy with a promoter targeting both rods and cones rescues retinal degeneration caused by AIPL1 mutations. Gene Ther., 17, 117-131.
88. Gil, J.M., Leist, M., Popovic, N., Brundin, P. and Petersen, A. (2004) Asialoerythropoietin is not effective in the R6/2 line of Huntington's disease mice. BMC Neurosci., 5, 17.
89. Auricchio, A., O'Connor, E., Hildinger, M. and Wilson, J.M. (2001) A single-step affinity column for purification of serotype-5 based adeno-associated viral vectors. Mol. Ther., 4, 372-374.
90. Auricchio, A., Hildinger, M., O'Connor, E., Gao, G.P. and Wilson, J.M. (2001) Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column. Hum. Gene Ther., 12, 71-76.
91. Drittanti, L., Rivet, C., Manceau, P., Danos, O. and Vega, M. (2000) High throughput production, screening and analysis of adeno-associated viral vectors. Gene Ther., 7, 924-929.
92. Gao, G., Qu, G., Burnham, M.S., Huang, J., Chirmule, N., Joshi, B., Yu, Q.C., Marsh, J.A., Conceicao, C.M. and Wilson, J.M. (2000) Purification of recombinant adeno-associated virus vectors by column chromatography and its performance in vivo. Hum. Gene Ther., 11, 2079-2091.
93. Papaioannou, V.E. and Fox, J.G. (1993) Efficacy of tribromoethanol anesthesia in mice. Lab. Anim. Sci., 43, 189-192.
94. Liang, F.Q., Anand, V., Maguire, A.M. and Bennett, J. (2000) Intraocular Delivery of Recombinant Virus. Humana Press Inc., Totowa, NJ.
95. Allocca, M., Di Vicino, U., Petrillo, M., Carlomagno, F., Domenici, L. and Auricchio, A. (2007) Constitutive and AP20187-induced Ret activation in photoreceptors does not protect from light-induced damage. Invest. Ophthalmol. Vis. Sci., 48, 5199-5206.
96. Armentano, M., Chou, S.J., Tomassy, G.S., Leingartner, A., O'Leary, D.D. and Studer, M. (2007) COUP-TFI regulates the balance of cortical patterning between frontal/motor and sensory areas. Nat. Neurosci., 10, 1277-1286.